Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Molecular Therapeutics Overview Sparkline Graph

Graph co-Publications by faculty members in Molecular Therapeutics

Show all Molecular Therapeutics members

Publications (total of 2123)

no pagination
Li JS, Shahine B, Fourkal E, Ma CM. A particle track-repeating algorithm for proton beam dose calculation. Physics in Medicine and Biology. 2005 Mar 07;50(5):1001-10.
Ma CM, Li JS, Jiang SB, Pawlicki T, Xiong W, Qin LH, Yang J. Effect of statistical uncertainties on Monte Carlo treatment planning. Physics in Medicine and Biology. 2005 Mar 07;50(5):891-907.
Yang J, Li J, Chen L, Price R, McNeeley S, Qin L, Wang L, Xiong W, Ma CM. Dosimetric verification of IMRT treatment planning using Monte Carlo simulations for prostate cancer. Physics in Medicine and Biology. 2005 Mar 07;50(5):869-78.
Jin T, Howard AJ, Golemis EA, Wang Y, Zhang YZ. Overproduction, purification, crystallization and preliminary X-ray diffraction studies of the human spliceosomal protein TXNL4B. Acta Crystallographica Section F-Structural Biology and Crystallization Communications. 2005 Mar 03;61:282-4.
Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee HO, Wang H, Lai JH, Bachovchin WW, Weiner LM. Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Molecular Cancer Therapeutics. 2005 Mar;4(3):351-60.
Denlinger CS, Meropol NJ. The Olszewski/Grossbard/Kozuch article reviewed. ONCOLOGY-NEW YORK. 2005 Mar;19(3):329-+.
Fourkal E, Velchev I, Ma CM. Coulomb explosion effect and the maximum energy of protons accelerated by high-power lasers. Physical Review E Statistical, Nonlinear, & Soft Matter Physics. 2005 Mar;71(3 Pt 2B):036412.
Horwitz EM, Thames HD, Kuban DA, Levy LB, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Hanks GE, Zietman AL. Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: A multi-institutional pooled analysis. Journal of Urology. 2005 Mar;173(3):797-802.
Jacob R, Hanlon AL, Horwitz EM, Movsas B, Uzzo RG, Pollack A. Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement. International Journal of Radiation Oncology Biology Physics. 2005 Mar;61(3):695-701.
Tze LE, Schram BR, Lam KP, Hogquist KA, Hippen KL, Liu J, Shinton SA, Otipoby KL, Rodine PR, Vegoe AL, Kraus M, Hardy RR, Schlissel MS, Rajewsky K, Behrens TW. Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. Plos Biology. 2005 Mar;3(3):463-75.
Kaminski JM, Hanlon AL, Horwitz EM, Pinover WH, Mitra RK, Hanks GE. Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control. Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):888-92.
Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, Sigurdson ER, O'Dwyer PJ, Benson AB. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - An intergroup study. Journal of Clinical Oncology. 2002 Mar 15;20(6):1499-505.
Kahsay RY, Wan GL, Dongre N, Gao G, Dunbrack RL. CASA: a server for the critical assessment of protein sequence alignment accuracy. Bioinformatics (Oxford, England). 2002 Mar;18(3):496-7.
Kervinen J, Jaffe EK, Stauffer F, Neier R, Wlodawer A, Zdanov A. Mechanistic basis for suicide inactivation of porphobilinogen synthase by 4,7-dioxosebacic acid, an inhibitor that shows dramatic species selectivity. Biochemistry. 2001 Jul 27;40(28):8227-36.
Latypov RF, Dolgikh DA, Kirpichnikov MP, Ptitsyn OB, Roder H. [Y97V substitution in the horse cytochrome c causes accumulation of the equilibrium intermediate]. Biofizika. 2001 Jan;46(1):46-52.
McGuire WP, Ozols RF. Chemotherapy of advanced ovarian cancer (vol 25, pg 340, 1998). Seminars in Oncology. 1998 Dec;25(6):707.
Nemer M. Histone deacetylase mRNA temporally and spatially regulated in its expression in sea urchin embryos. Development Growth & Differentiation. 1998 Dec;40(6):583-90.
Paz-Ares L, Kunka R, DeMaria D, Cassidy J, Alden M, Beranek P, Kaye S, Littlefield D, Reilly D, Depee S, Wissel P, Twelves C, O'Dwyer P. A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion. British Journal of Cancer. 1998 Nov;78(10):1329-36.
Plank TL, Yeung RS, Henske EP. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Research. 1998 Nov;58(21):4766-70.
Rhee PH, Friedman CD, Ridge JA, Kusiak J. The use of processed allograft dermal matrix for intraoral resurfacing - An alternative to split-thickness skin grafts. Archives of Otolaryngology-Head & Neck Surgery. 1998 Nov;124(11):1201-4.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications by faculty members in Molecular Therapeutics

Show All Units
Last updated on Wednesday, February 05, 2020